Loading...
OTCM
MCUJF
Market cap10mUSD
Dec 01, Last price  
0.81USD
1Q
14.61%
Jan 2017
-89.58%
Name

Medicure Inc

Chart & Performance

D1W1MN
OTCM:MCUJF chart
P/E
—
P/S
0.54
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-7.00%
Rev. gr., 5y
1.66%
Revenues
22m
+0.98%
299,7375,944,7302,247,1294,792,5133,317,0733,628,2744,796,8112,602,7005,050,7619,024,67922,083,12837,778,47127,132,83229,109,36520,173,00011,610,00021,744,00023,065,00021,694,00021,907,000
Net income
-1m
L+12.69%
-12,607,074-31,703,386-57,402,521-13,315,827-5,532,506-2,014,10923,385,779-2,574,304-1,638,9522,049,5931,668,42927,657,47443,420,8843,925,639-19,786,000-6,894,000-727,0001,365,000-922,000-1,039,000
CFO
1m
-33.77%
-12,678,498-25,246,653-41,864,640-10,418,139-1,452,809477,479417,289-990,478110,880473,969142,7956,410,81121,923,132742,273-14,641,000-2,240,0003,989,0001,828,0002,079,0001,377,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
URL
https://www.medicure.com/
IPO date
Mar 30, 1999
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT